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ABSTRACT
Objective: The purpose of the present study was to identify the fermenting and non-fermenting Gram-negative bacteria from the tertiary care hospital.
Methods: The conventional method of identification by biochemical analysis and antibiotic susceptibility test was performed by Kirby-Bauer disc 
diffusion method. Furthermore, analysis of microbes was done by Vitek-2.
Results: 424 strains of lactose fermenting Gram-negative bacilli (LFGNB) and non-LFGNB (NLFGNB) were isolated from 3097 clinical samples. From 
the total LF bacteria, Escherichia coli was the predominant isolate accounting for 50.94% specimens, followed by Klebsiella pneumoniae 27.59% and 
Enterobacter 0.47%. From the total NLFGNB, Acinetobacter baumannii was the predominant isolate accounting for 12.73% specimens followed by 
Pseudomonas aeroginosa 6.13%, other isolates were Stenotrophomonas maltophilia 1.17%, Burkholderia cepacia 0.94%. In the present study, male 
were more infected than female. The study also showed that LF bacteria were more infectious than non LF bacteria and isolates were from urine 
samples.
Conclusion: Both NLFGNB and LFGNB Gram-negative bacilli were found to be major contaminants, and are important pathogenic bacteria causing a 
wide range of infections in the tertiary care hospital.
Keywords: Lactose fermenting Gram-negative bacteria, Vitek-2, Tertiary care hospital, Kirby-Bauer disc diffusion, Lactose non-fermenting Gram-
negative bacteria.
INTRODUCTION
The emergence of antibiotic resistance is due to excessive and often 
unsupervised use of antibiotics in humans and animals. Risk factors 
for the spread of resistant bacteria in hospitals and the community are 
due to lapse in hygiene or poor infection control practices. Increasing 
antibiotic resistance in bacteria has been aggravated by the slow pace 
in developing newer antibiotics. The present study focused mainly 
on Enterobacteriaceae which are lactose fermenters (LFs) and some 
non-lactose such as Pseudomonas aeroginosa and Acinetobacter 
baumannii. The purpose of clinical microbiology is to isolate and identify 
pathogenic microorganism and to assist in the diagnosis, management, 
and treatment of infectious diseases. Immunocompromised patients 
are highly susceptible to environmental strain which aggravate with 
invasive techniques such as catheterization, bronchoscopy, colposcopy, 
or surgical biopsies [1].
These organisms can occur frequently as components of commensal 
flora of man and animals and are regular contaminants of the hospital 
environment. These pathogens have been implicated in various ranges 
of infections. These bacteria are emerging opportunistic organisms 
causing a wide variety of nosocomial infections such as infectious 
wounds, ventilators associated pneumonia, blood stream infection, 
intensive care unit infection, and urinary tract infection (UTI) [2].
Methicillin-resistant Staphylococcus aureus (MRSA), 
vancomycin-resistant Enterococci (VRE) and multi-drug resistant Gram-
negative bacteria can spread by direct or indirect person-to-person 
contact. Independent risk factors for MRSA include the use of broad 
spectrum antibiotics, the presence of decubitus ulcers and prosthetic 
devices while those for VRE include prolonged hospitalization and 
treatment with glycopeptides or broad spectrum antibiotics. For 
the spread of resistant Gram-negative bacteria, risk factors include 
urinary catheterization, excessive use of antibiotics, contaminants of 
humidifiers and nebulizers.
The spread of penicillin-resistant pneumococci (PRP) and drug-
resistant/multidrug-resistant tuberculosis (MDRTb) is due to airborne 
transmission. Risk factors for the spread of PRP include overcrowding, 
tracheostomies and excessive use of penicillins for viral respiratory 
infections; for MDRTb they include poor compliance, the convergence 
of immunosuppressed patients, delayed diagnosis or treatment, and 
poor or inadequate ventilation and isolation facilities [3].
The main LF organism includes Escherichia coli, Klebsiella pneumoniae, 
and non-LF organisms include A. baumannii, Pseudomonas aeruginosa, 
Stenotrophomonas maltophillia, and Burkholderia cepcia. In hospital 
environment, these non-fermenting Gram-negative bacilli affect 
seriously ill patients by interfering with the treatment and may also lead 
to septicemia. The cause of infection could be the hospital environment, 
i.e., mainly device related infections which are often resistant to 
disinfectants. Devices have the potential to spread the infection from 
patient-to-patient via fomites or hands of medical personnel’s along 
with that they spread from soap cakes for hand washing in hospitals or 
through dust on the baby weighing machines [4].
Extended spectrum beta-lactamase (ESBLs) are enzymes conferring 
broad resistance to penicillin, cephalosporin, and monobactam but not 
to carbapenem [5]. ESBLs are often plasmid mediated, and most are 
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members of TEM-1, TMH-2 and SHV-1 family of enzymes. These enzymes 
are produced by Enbterobacteriaceae mainly by E. coli, K. pneumoniae, 
and Klebsiella oxytoca. They have been detected in other Gram-negative 
bacilli such as Salmonella species, Proteus spp., P. aeruginosa, and other 
Enteobacteiaceae [6]. Resistant to beta-lactamase is most commonly 
associated with the production of high levels of naturally produced 
cephalosporinase [7]. Carbapenem resistance is primarily caused by 
two mechanisms, either by reducing intracellular concentration or by 
hydrolysis of the drug [8]. Penicillin binding proteins all may contribute 
to carbapenem resistance.
Developing a resistance to antibiotics is natural to microbes, which 
cannot primarily be a cause of constantly involving nature of microbes to 
chemical around them. There are different mechanisms for resistance in 
Gram-negative bacilli as production of enzymes, enzymatic inactivation 
of antimicrobial agents, alternations in target sites, loss of outer 
membrane proteins, spontaneous mutation, or by DNA transfer [9]. 
The phenomenon is very important regarding it partial and economic 
implications.
The patients who receive long courses of broad-spectrum antibiotics, 
corticosteroids antimetabolites or anticancer drugs or undergo 
complete surgical procedures and AIDS patients are more prone to 
be infected by these pathogens which are resistant to multiple drugs. 
These microorganisms have survived for thousands of years by their 
ability to adapt to antimicrobial agents [10].
METHODS
Source of sample collection
Totally, 3097 samples from the clinically suspected cases were 
collected from a tertiary care health setup. The samples were received 
in the microbiology laboratory such as blood, tissue, pus; respiratory 
samples were - Endotracheal secretion, bronchoalveolar lavage (BAL), 
sputum. Aseptic conditions were strictly maintained throughout the 
examinations.
Isolation of bacterial isolates and identification
Samples were cultured according to the sample type as urine sample 
platted on CLED agar, and respiratory samples were platted on blood 
agar, MacConkey agar, and chocolate agar. Other samples were platted 
on blood agar, MacConkey and brain heart infusion broth such as pus 
and tissue. Blood samples were platted on blood, and MacConkey agar 
and smears were prepared of all the samples for Gram-staining except 
urine samples. They were allowed to incubate at 37°C for 24 hrs. The 
bacterial isolates were observed for colony morphology, hemolytic 
pattern, and gram’s reaction. Biochemical tests were performed for 
identification of bacterial strains as per the Standard Conventional 
Method [11].
Antibiotic susceptibility testing
Antibiotic susceptibility test of bacterial isolates was performed 
according to the criteria of Clinical and performed Laboratory 
Standards Institute [12] using the Kirby-Bauer disc diffusion on Muller-
Hinton agar (MHA). Isolates were grown in peptone water at 37°C 
turbidity was matched with 0.5 McFarland standards [13]. The lawn 
culture was done on MHA plate, and antibiotics disc were placed. Plates 
were incubated at 37°C overnight and zone of inhibition was observed 
according to CLSI guidelines [14]. Plates were observed after 24 hrs 
as inhibition zone diameter sensitive, resistant, and intermediate 
ESBL positive isolates were isolated. ESBL isolates were tested with 
ceftazidime and ceftazidime-clavulanic acid on MHA agar.
Vitek-2
Instrument based on colorimetric measurements for the identification 
as well as antibiotic susceptibility cards were used for higher accuracies.
Modified Hodge test (MHT)
All the carbapenem resistant strains were subjected to MHT for 
detection of carbapenemases. The suspension of ATCC E. coli 25922 
was prepared in comparison to 0.5 McFarland standard in 5 ml of sterile 
saline using the direct colony suspension. A 4.5 ml of sterile saline was 
pipetted out into a sterile tube. Then, 0.5 ml of the ATCC E. coli 25922 
suspension was added to 4.5ml of saline to make a 1:10 dilution. Diluted 
ATCC E. coli 25922 was inoculated to an MH plate containing 70µg/mL 
of zinc sulfate and then streaked over the entire plate with the help of 
sterile cotton swab. A 10 µg meropenem susceptibility disk was placed 
in the center of the MH plate. Then the test organism, positive control 
(K. pneumoniae ATCC BAA-1706) and negative control (K. pneumoniae 
ATCC BAA-1705), was streaked in a straight line from the edge of the 
meropenem disk to the edge of the plate and then incubated at 35±2°C 
in ambient air for 16-20 hrs. Carbapenemase production was detected 
by the appearance of the enhanced ATCC E. coli 25922 growth along 
the test organism that revealed a clover-leaf-like indentation which 
indicated a positive test.
RESULTS
A total of 424 strains of LF Gram-negative bacilli (LFGNB) and non-
LFGNB (NLFGNB) were isolated from 3097 clinical samples accounting 
for an isolation rate of 13.69% out of the total samples. The clinical 
specimen included urine 45.51% blood 24.76%, ET 8.72%, sputum 
3.77%, and BAL 2.12%, Pus 15.09% (Figs. 1 and 2).
From the total LFGNB, E. coli was the predominant isolate accounting 
50.94% specimens followed by K. pneumoniae 27.59%; other isolate 
was Enterobacter 0.47% (Fig. 3). The total NLFGNB A. baumannii was 
the predominant isolate accounting 12.73% specimens followed by P. 
aeroginosa 6.13% other isolates were Stenotrophomonas maltophilia 
1.17%, Burkholderia Lepacia 0.94% (Fig. 4).
Out of the total patients, 53.77% of the patients accounted for males 
and 46.22% were female (Fig. 5).
The isolates were found to be maximum when the duration of stay of 
the patient was 0-10 days, i.e., 39.62% patient followed by duration 
of stay of more than 30 days, i.e., 29.71% patients were infected with 
LFGNB and NLFGNB. While when the duration of stay was 10-20 days 
23.11% were suffering from the infection and when the duration was 
20-30 days 7.54% of the infection (Fig. 6). The patients aged between 
40 and 75 years were more infected, i.e., 62.26% while age group of 
30-45 years account 17.92% patient of age group 15-30 were 7.54%. 
Patient with age group of 75-80 years 5.42% patient with age group of 
0-10 were 3.77 and >80 age group were 3.06% patients (Fig. 7).
A significant decrease of antibiotic susceptibility was seen. Different 
antibiotics used were tested which included amikacin (AK), 
gentamicin (CN), cefuroxime (CXM), cefixime (CFM), cefotaxime (CTX), 
ceftazidime (CAZ), ceftriaxone (CRO), sulbactam/cefoperazone (SCF), 
ciprofloxacin (CIP), colistin, levofloxacin (LEV), moxifloxacin (MOX), 
Fig. 1: Total clinical isolates
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Isolation of ESBL
It was observed that of a total of 335 isolates of Enterobacteriaceae 
strains, 218 were ESBL positive 65.07% over a period of 2 months 
detected with the help of VITEK 2 DensiChek instrument and manual 
method in MHA plates [17].
The plate was divided into two parts. These were again tested with 
ceftazidime and ceftazidime-clavulanic acid discs on one side, and 
E-test of cefotaxime and cefotaxime-clavulanic acid was placed on the 
other half. After overnight incubation, the plates were observed. An 
increase in the zone diameter ≥5 mm between the antibiotic alone and 
in combination was considered as ESBL positive. This is the screening 
test used for the detection of ESBL producer. Further, E-test (cefotaxime 
on one end, cefotaxime/clavulanic acid on other end) was performed 
on total isolates and compared. The strains with ratio of cefotaxime 
minimal inhibitory concentration (MIC) and cefotaxime–clavulanic acid 
MIC ≥8 indicated the presence of ESBL.
DISCUSSION
In the present study, LFs 335 (79%) were predominant, compared 
to non-LFs 89 (20.99%) where the majority of LF were isolated from 
Fig. 2: Percentage of lactose fermenting Gram-negative bacilli 
(LFGNB) and non NLFGNB of the total isolates
Fig. 3: Percentage of micro-organisms amongst lactose 
fermenting Gram-negative bacilli
Fig. 4: Percentage of the different micro-organisms among non-
lactose fermenting Gram-negative bacilli
meropenem (MEM), imipenem (IPM), colistin sulphate (CT), and 
piperacillin/tazobactam (TZP). The most active antibiotics against LF 
and non-LF was colistin accounting almost 98% followed by amikacin 
(60%) and cefoperazone (50%) [15]. In some specimens, carbapenems 
(imepenem and merapenem) showed susceptibility while in most of 
the cases it was found to be resistant. A few specimens were multidrug 
resistant. Carbapenem resistance was observed in 58.9% A. baumannii 
out of 112 clinical isolates by Vitek-2 and Kirby-Bauer disk diffusion 
method [16]. Therefore, the carbapenem resistant isolates were 
subjected for carbapenemase production by MHT and 83.3% were 
carbapenemase producers.
Fig. 6: Percentage of patients of different age groups
Fig. 5: Percentage of infected males and females
Fig. 7: Percentage of infection as per duration of stay
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urine samples. Enterobacteriaceae were among the leading causes of 
nosocomial infection. The most common isolate was E. coli, followed 
by K. pneumoniae in our study. Non-fermenting Gram-negative bacilli 
were considered to be a contaminant in the past, however, it has been 
observed that emerges of the strains has shown as an important 
health-care pathogen [18].
Similarly from a study from the All India Institute of Medical Sciences, 
New Delhi, in 2002 showed that 68% of the Enterobacteriaceae were 
ESBL producing strains [19].
The unusually high prevalence of ESBL producers in the present study 
was due to the overcrowded large tertiary care referral center, and the 
majority of infections were nosocomially acquired [20].
In a study from Kolar, Karnataka showed saprophytic nature of 
non-fermenting Gram-negative bacilli as the potent pathogen that 
exhibits resistant not only to beta-lactam and other antibiotics but also 
to carbapenems [21]. The sensitivity test was performed by Kirby-Bauer 
disc diffusion methods.
In our study, the most common non-fermenting Gram-negative bacilli 
were P. aeroginosa (53.8%) followed by A. baumannii (22.2%) and 
others (11.4%). Similarly, from a study from Delhi has reported that 
172 samples were identified as non-fermenting Gram-negative bacilli 
out of 1526 respiratory samples. A. baumannii was the predominant 
isolate accounting 59.88% specimens followed by P. aeroginosa 33.13% 
other isolates were S. maltophilia 5.23% and Burkholderia cepacia 1.74% 
from the total samples. A. baumannii and P. aeroginosa were the most 
common non-fermenting Gram-negative bacilli isolated in the study of 
patients concerning respiratory tract infection was reported [14].
P. aeroginosa was the most prevalent pathogen amongst the 
Gram-negative bacilli in our study. P. aeroginosa was found to be 
sensitive to imipenem (94.2%) cefoperazone (70.5%), amikacin (69%) 
and ticarcillin (63%). Whereas A. baumannii was found to be 100% 
sensitive to imepenem and 70% to penicillin and 35% to amikacin. 
S. maltophillia was 100% sensitive to cotrimoxazole and ciprofloxacin 
(Fig. 8). All the carbapenem resistant strains were subjected to MHT for 
carbapenemase production, wherein 83.3% strains were found to be 
carbapenemase producers while a study from South India reported that 
71% of isolates were carbapenemase producers by MHT [22].
From the study conducted in Uttar Pradesh reported that E. coli was 
highly sensitive to nitrofurantoine [23].
Furthermore, from a study by Daza et al. had shown that nitrofurantoine 
should be used as antibiotic if E. coli is identified. Nitrofurantoine 
can be an appropriate agent as the first treatment of UTI in the India 
population [24].
Similarly in the present study that E. coli was 100% sensitive to 
nitrofurantoine, imipenem, and netilmicin, and was highly resistant 
to ampicillin, while Klebsiella species had shown high sensitivity to 
imipenem and resistance to ampicillin and amoxicillin/clavaunic acid. 
The effective drugs for P. aeroginosa were gentamycin, ceftazidime, 
piperacillin/tazobactam, nitrofurantoin, norfloxacin, polymcin-B, and 
colistin.
In the present study, it has been found that out of the total admitted 
patients 53.77% of the patients accounted for males and 46.22% were 
females. Male patients have been found more infected than female. 
It showed that males are more susceptible to the infection caused 
by LFGNB and NLFGNB. Similar trends have also been reported by a 
study of Eastern India, where 55% patients were males and 45% were 
females [25]. While study from Rotak has revealed that males and 
females were equally susceptible to the infection [21].
We have also observed that the longer the duration of patient’s stay at 
the hospital more is the susceptibility to LFGNB and NLFGNB.
CONCLUSION
We the authors would like to conclude that the contamination in 
overcrowded tertiary care hospitals is more as compared to the well 
sanitized and ventilated hospitals. Infection was more predominant 
in males as compared to females, longer the duration of stay higher 
is the chance to get infected. Dominant LFGNB was found to be E. coli. 
However, non-fermenting Gram-negative bacilli were P. aeroginosa and 
A. baumannii.
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